Patient Video - What was the comprehensive biomarker testing experience like?
Chris explains what his experience was like having comprehensive biomarker testing for his lung cancer, how long he had to wait for results, and what the overall process involved. After having a liquid biopsy and pleuroscopy, his medical team was able to extract additional tissue samples that confirmed he had the KRAS G12C lung cancer mutation.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
Slide Show - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
4.
How do doctors treat lung cancer with KRAS mutations?
5.
How did you find out you had KRAS-positive lung cancer?
6.
What was the comprehensive biomarker testing experience like?
7.
What has your treatment experience been for your KRAS-positive lung cancer?
8.
What advice do you have for newly diagnosed lung cancer patients about biomarker testing?
9.
How did you find out you had KRAS-positive lung cancer?
10.
How has your KRAS mutation affected the treatment options available to you?
